Vaxart, Inc. Operating Expenses
Vaxart, Inc. (VXRT) reported Operating Expenses of $40.36 million for the 3-month period ending 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Expense Statement › Operating Expenses
us-gaap:OperatingExpenses · last filed 2026-08-06
- Vaxart, Inc. operating expenses for the quarter ending 2026-06-30 was $40.36M, a 25.72% decline year-over-year.
- Vaxart, Inc. operating expenses for the quarter ending 2026-03-31 was $34.05M, a 4.91% decline year-over-year.
- Vaxart, Inc. operating expenses for the quarter ending 2025-12-31 was $48.82M, a 82.99% increase year-over-year.
- Vaxart, Inc. operating expenses for the quarter ending 2025-09-30 was $80.22M, a 313.36% increase year-over-year.
- Vaxart, Inc. operating expenses for fiscal 2023 was $90.73M, a 20.90% decline from fiscal 2022.
- Vaxart, Inc. operating expenses for fiscal 2022 was $114.69M, a 55.74% increase from fiscal 2021.
- Vaxart, Inc. operating expenses for fiscal 2021 was $73.64M, a 115.23% increase from fiscal 2020.
- Vaxart, Inc. operating expenses for fiscal 2020 was $34.22M, a 33.41% increase from fiscal 2019.
| Period end | Operating Expenses 3 month | Operating Expenses 6 month | Operating Expenses 9 month | Operating Expenses 12 month |
|---|---|---|---|---|
| 2026-06-30 | $40.36M 10-Q · filed 2026-08-06 | $74.41M 10-Q · filed 2026-08-06 | $123.23M derived: sum of 3 quarters · filed 2026-08-06 | $203.45M derived: sum of 4 quarters · filed 2026-08-06 |
| 2026-03-31 | $34.05M S-1 · filed 2026-05-08 | $82.87M derived: sum of 2 quarters · filed 2026-05-08 | $163.09M derived: sum of 3 quarters · filed 2026-05-08 | $217.43M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-12-31 | $48.82M derived: S-1 12 month − 10-Q 9 month · filed 2026-05-08 | $129.04M derived: sum of 2 quarters · filed 2026-05-08 | $183.37M derived: sum of 3 quarters · filed 2026-08-06 | $219.18M S-1 · filed 2026-05-08 |
| 2025-09-30 | $80.22M 10-Q · filed 2025-11-13 | $134.56M derived: sum of 2 quarters · filed 2026-08-06 | $170.37M 10-Q · filed 2025-11-13 | $197.04M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-06-30 | $54.33M 10-Q · filed 2026-08-06 | $90.14M 10-Q · filed 2026-08-06 | $116.82M derived: sum of 3 quarters · filed 2026-08-06 | $136.23M derived: sum of 4 quarters · filed 2026-08-06 |
| 2025-03-31 | $35.81M S-1 · filed 2026-05-08 | $62.49M derived: sum of 2 quarters · filed 2026-05-08 | $81.90M derived: sum of 3 quarters · filed 2026-05-08 | $104.55M derived: sum of 4 quarters · filed 2026-05-08 |
| 2024-12-31 | $26.68M derived: S-1 12 month − 10-Q 9 month · filed 2026-05-08 | $46.09M derived: sum of 2 quarters · filed 2026-05-08 | $68.74M derived: sum of 3 quarters · filed 2026-05-08 | $94.99M S-1 · filed 2026-05-08 |
| 2024-09-30 | $19.41M 10-Q · filed 2025-11-13 | $42.06M derived: sum of 2 quarters · filed 2025-11-13 | $68.32M 10-Q · filed 2025-11-13 | $88.46M derived: sum of 4 quarters · filed 2025-11-13 |
| 2024-06-30 | $22.66M 10-Q · filed 2025-08-13 | $48.91M 10-Q · filed 2025-08-13 | $69.05M derived: sum of 3 quarters · filed 2025-08-13 | $88.98M derived: sum of 4 quarters · filed 2025-08-13 |
| 2024-03-31 | $26.25M 10-Q · filed 2025-05-13 | $46.40M derived: sum of 2 quarters · filed 2025-05-13 | $66.32M derived: sum of 3 quarters · filed 2025-05-13 | $90.73M derived: sum of 4 quarters · filed 2025-05-13 |
| 2023-12-31 | $20.14M derived: 10-K 12 month − 10-Q 9 month · filed 2025-03-20 | $40.07M derived: sum of 2 quarters · filed 2025-03-20 | $64.48M derived: sum of 3 quarters · filed 2025-03-20 | $90.73M 10-K · filed 2025-03-20 |
| 2023-09-30 | $19.92M 10-Q · filed 2024-11-13 | $44.33M derived: sum of 2 quarters · filed 2024-11-13 | $70.58M 10-Q · filed 2024-11-13 | $101.74M derived: sum of 4 quarters · filed 2024-11-13 |
| 2023-06-30 | $24.41M 10-Q · filed 2024-08-08 | $50.66M 10-Q · filed 2024-08-08 | $81.82M derived: sum of 3 quarters · filed 2024-08-08 | $111.24M derived: sum of 4 quarters · filed 2024-08-08 |
| 2023-03-31 | $26.25M 10-Q · filed 2024-05-13 | $57.41M derived: sum of 2 quarters · filed 2024-05-13 | $86.83M derived: sum of 3 quarters · filed 2024-05-13 | $116.08M derived: sum of 4 quarters · filed 2024-05-13 |
| 2022-12-31 | $31.16M derived: 10-K 12 month − 10-Q 9 month · filed 2024-03-14 | $60.59M derived: sum of 2 quarters · filed 2024-03-14 | $89.83M derived: sum of 3 quarters · filed 2024-03-14 | $114.69M 10-K · filed 2024-03-14 |
| 2022-09-30 | $29.43M 10-Q · filed 2023-11-02 | $58.67M derived: sum of 2 quarters · filed 2023-11-02 | $83.53M 10-Q · filed 2023-11-02 | $107.82M derived: sum of 4 quarters · filed 2023-11-02 |
| 2022-06-30 | $29.25M 10-Q · filed 2023-08-03 | $54.11M 10-Q · filed 2023-08-03 | $78.40M derived: sum of 3 quarters · filed 2023-08-03 | $95.85M derived: sum of 4 quarters · filed 2023-08-03 |
| 2022-03-31 | $24.86M 10-Q · filed 2023-05-04 | $49.15M derived: sum of 2 quarters · filed 2023-05-04 | $66.60M derived: sum of 3 quarters · filed 2023-05-04 | $82.49M derived: sum of 4 quarters · filed 2023-05-04 |
| 2021-12-31 | $24.29M 10-K · filed 2022-02-24 | $41.74M derived: sum of 2 quarters · filed 2022-11-09 | $57.63M derived: sum of 3 quarters · filed 2022-11-09 | $73.64M 10-K · filed 2023-03-15 |
| 2021-09-30 | $17.45M 10-Q · filed 2022-11-09 | $33.34M derived: sum of 2 quarters · filed 2022-11-09 | $49.35M 10-Q · filed 2022-11-09 | $63.07M derived: sum of 4 quarters · filed 2022-11-09 |
| 2021-06-30 | $15.89M 10-Q · filed 2022-08-08 | $31.90M 10-Q · filed 2022-08-08 | $45.62M derived: sum of 3 quarters · filed 2022-08-08 | $53.48M derived: sum of 4 quarters · filed 2022-08-08 |
| 2021-03-31 | $16.02M 10-Q · filed 2022-05-09 | $29.73M derived: sum of 2 quarters · filed 2022-05-09 | $37.59M derived: sum of 3 quarters · filed 2022-05-09 | $46.64M derived: sum of 4 quarters · filed 2022-05-09 |
| 2020-12-31 | $13.72M 10-K · filed 2022-02-24 | $21.57M derived: sum of 2 quarters · filed 2022-02-24 | $30.62M derived: sum of 3 quarters · filed 2022-02-24 | $34.22M 10-K · filed 2022-02-24 |
| 2020-09-30 | $7.85M 10-K · filed 2022-02-24 | $16.90M derived: sum of 2 quarters · filed 2022-02-24 | $20.50M 10-Q · filed 2021-11-04 | $30.04M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-06-30 | $9.05M 10-K · filed 2022-02-24 | $12.64M 10-Q · filed 2021-08-05 | $22.19M derived: sum of 3 quarters · filed 2022-02-24 | $27.36M derived: sum of 4 quarters · filed 2022-02-24 |
| 2020-03-31 | $3.60M 10-K · filed 2022-02-24 | $13.14M derived: sum of 2 quarters · filed 2022-02-24 | $18.31M derived: sum of 3 quarters · filed 2022-02-24 | $23.39M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-12-31 | $9.54M 10-K · filed 2022-02-24 | $14.71M derived: sum of 2 quarters · filed 2022-02-24 | $19.79M derived: sum of 3 quarters · filed 2022-02-24 | $25.65M 10-K · filed 2022-02-24 |
| 2019-09-30 | $5.17M 10-K · filed 2022-02-24 | $10.25M derived: sum of 2 quarters · filed 2022-02-24 | $16.11M 10-Q · filed 2020-11-12 | $22.06M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-06-30 | $5.08M 10-K · filed 2022-02-24 | $10.94M 10-Q · filed 2020-08-06 | $16.89M derived: sum of 3 quarters · filed 2022-02-24 | $23.05M derived: sum of 4 quarters · filed 2022-02-24 |
| 2019-03-31 | $5.86M 10-K · filed 2022-02-24 | $11.81M derived: sum of 2 quarters · filed 2022-02-24 | $17.97M derived: sum of 3 quarters · filed 2022-02-24 | $26.35M derived: sum of 4 quarters · filed 2022-02-24 |
| 2018-12-31 | $5.95M 10-K · filed 2021-02-25 | $12.11M derived: sum of 2 quarters · filed 2021-02-25 | $20.50M derived: sum of 3 quarters · filed 2021-02-25 | $25.91M 10-K · filed 2021-02-25 |
| 2018-09-30 | $6.16M 10-K · filed 2021-02-25 | $14.54M derived: sum of 2 quarters · filed 2021-02-25 | $19.96M 10-Q · filed 2019-11-12 | $23.41M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-06-30 | $8.38M 10-K · filed 2021-02-25 | $13.80M 10-Q · filed 2019-08-08 | $17.25M derived: sum of 3 quarters · filed 2021-02-25 | $20.12M derived: sum of 4 quarters · filed 2021-02-25 |
| 2018-03-31 | $5.42M 10-K · filed 2021-02-25 | $8.87M derived: sum of 2 quarters · filed 2021-02-25 | $11.74M derived: sum of 3 quarters · filed 2021-02-25 | $16.71M derived: sum of 4 quarters · filed 2021-02-25 |
| 2017-12-31 | $3.45M 10-K · filed 2019-02-06 | $6.32M derived: sum of 2 quarters · filed 2019-02-06 | $11.30M derived: sum of 3 quarters · filed 2019-02-06 | $15.85M derived: sum of 4 quarters · filed 2019-02-06 |
| 2017-09-30 | $2.87M 10-K · filed 2019-02-06 | $7.85M derived: sum of 2 quarters · filed 2019-02-06 | $12.40M derived: sum of 3 quarters · filed 2019-02-06 | |
| 2017-06-30 | $4.98M 10-K · filed 2019-02-06 | $9.53M derived: sum of 2 quarters · filed 2019-02-06 | ||
| 2017-03-31 | $4.56M 10-K · filed 2019-02-06 | |||
| 2012-09-30 | $4.75M 10-Q · filed 2012-11-08 | $8.26M derived: sum of 2 quarters · filed 2012-11-08 | $11.05M 10-Q · filed 2012-11-08 | $13.89M derived: sum of 4 quarters · filed 2012-11-08 |
| 2012-06-30 | $3.51M 10-Q · filed 2012-08-09 | $6.30M 10-Q · filed 2012-08-09 | $9.14M derived: sum of 3 quarters · filed 2012-08-09 | $15.17M derived: sum of 4 quarters · filed 2012-08-09 |
| 2012-03-31 | $2.79M 10-Q · filed 2012-05-10 | $5.64M derived: sum of 2 quarters · filed 2012-05-10 | $11.66M derived: sum of 3 quarters · filed 2012-05-10 | $20.09M derived: sum of 4 quarters · filed 2012-08-09 |
| 2011-12-31 | $2.84M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-14 | $8.87M derived: sum of 2 quarters · filed 2012-03-14 | $17.30M derived: sum of 3 quarters · filed 2012-08-09 | $24.60M 10-K · filed 2012-03-14 |
| 2011-09-24 | $6.02M 10-Q · filed 2012-11-08 | $14.45M derived: sum of 2 quarters · filed 2012-08-09 | $21.76M 10-Q · filed 2012-11-08 | $32.22M derived: sum of 4 quarters · filed 2012-08-09 |
| 2011-06-25 | $8.43M 10-Q · filed 2012-08-09 | $15.73M 10-Q · filed 2012-08-09 | $26.19M derived: sum of 3 quarters · filed 2012-08-09 | $35.25M derived: sum of 4 quarters · filed 2012-08-09 |
| 2011-03-26 | $7.30M 10-Q · filed 2012-05-10 | $17.76M derived: sum of 2 quarters · filed 2012-05-10 | $26.82M derived: sum of 3 quarters · filed 2012-05-10 | |
| 2010-12-25 | $10.46M derived: 10-K 12 month − 10-Q 9 month · filed 2012-03-14 | $19.52M derived: sum of 2 quarters · filed 2012-03-14 | $36.20M 10-K · filed 2012-03-14 | |
| 2010-09-25 | $9.06M 10-Q · filed 2011-11-02 | $25.74M 10-Q · filed 2011-11-02 | ||
| 2009-12-26 | $28.46M 10-K · filed 2012-03-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Kalaris Therapeutics, Inc. (KLRS) | United States | $0.073B | -2.19 |
| Atara Biotherapeutics, Inc. (ATRA) | United States | $0.086B | -6.48 |
| Pelthos Therapeutics Inc. (PTHS) | United States | $0.086B | -1.20 |
| CHAMPIONS ONCOLOGY, INC. (CSBR) | United States | $0.070B | -68.02 |
| COGNITION THERAPEUTICS INC (CGTX) | United States | $0.090B | -6.52 |
| BioStem Technologies, Inc. (BSEM) | United States | $0.069B | |
| Eloxx Pharmaceuticals, Inc. (ELOX) | United States | $0.065B | |
| MiNK Therapeutics, Inc. (INKT) | United States | $0.063B | -5.37 |
| Cardiff Oncology, Inc. (CRDF) | United States | $0.101B | -2.22 |
| EXOZYMES INC. (EXOZ) | United States | $0.058B |